PRA International Experts Present a Session at the 8th Annual Partnerships in Clinical Trials 2009

RALEIGH, North Carolina -

PRA International, a leading Clinical Research Organization, announces that its experts will present at a session during the 8th Annual Partnerships in Clinical Trials 2009 to be held 4 - 5 November 2009 at the World Trade Centre in Rotterdam, The Netherlands. PRA operational and therapeutic leaders are also attending the conference. PRA is exhibiting at booth number 32.

On 4 November, PRA’s Christian Tucat, Senior Vice President of Business Development, Europe participates in a session entitled Emerging markets: Where next? In this session, Edward C. Ian, Senior Director of Clinical Operations, Asia-Pacific will share his expertise in conducting studies in emerging regions. Mr. Ian will also discuss the industry’s move to emerging regions. The main focus of his presentation will be on the evolved Asia region; however, he will provide an overview of other emerging markets (i.e., Latin America, Africa and the Middle East). Drawing on his current experiences, he will discuss the regional benefits and challenges and offer practical advice on taking a systematic approach to country selection and site identification.

At PRA, Mr. Ian heads clinical operations for India, Singapore, China, Hong Kong, Korea, Australia, and Taiwan as well as PRA’s International Partner Program. Mr. Ian has more than 14 years experience in clinical research.

As the head of European sales for PRA, Mr. Tucat’s main responsibility is to serve PRA’s clients in Europe ensuring customer satisfaction and building long-term partnerships with both existing and new clients. Mr. Tucat has worked in the pharmaceutical industry for over 11 years.

About PRA International

PRA International conducts clinical trials in more than 75 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in oncology, neurosciences, respiratory/allergy, cardiovascular and infectious diseases. PRA has supported over 2,100 clinical trials through its 36 global offices.

PRA’s therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development life cycle.

To learn more about PRA International, please visit www.PRAinternational.com, email Endpoints@PRAintl.com or call our Global Headquarters at +1-919-786-8200.

Source: PRA International

Roger Boutin, Director of Marketing of PRA International, Inc., +1-434-951-3924